Cogent Biosciences Inc (NAS:COGT)
$ 8.58 -0.22 (-2.5%) Market Cap: 820.36 Mil Enterprise Value: 644.42 Mil PE Ratio: 0 PB Ratio: 4.11 GF Score: 30/100

Kiq LLC, Unum Therapeutics Inc. - M&A Call Transcript

Jul 06, 2020 / 02:30PM GMT
Release Date Price: $8.8 (+394.60%)
Operator

Good morning, and welcome to the Unum Therapeutics Kiq acquisition conference call. (Operator Instructions) Please be advised that the call is being recorded. Now I'd like to turn the call over to John Green, Chief Financial Officer of Unum. Please proceed.

John L. Green
Unum Therapeutics Inc. - CFO, Principal Accounting Officer, Principal Financial Officer, VP of Finance & Controller

Thank you, operator, and good morning, everyone. Earlier today, we issued a press release that outlined the acquisition of Kiq by Unum Therapeutics. This release is available at unumrx.com under the Investors tab.

During the call today, Chuck Wilson, President and CEO, will provide an overview of the acquisition of Kiq LLC by Unum and the vision for the company. And Peter Harwin, Kiq co-founder, managing member at Fairmount Funds, and newly appointed Board member, will review the details of the acquisition and information on the company's lead program, PLX9486.

Before we begin, I would like to remind everyone that statements made during this conference call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot